Asthma can be a real challenge, right? Whether it is wheezing, coughing, or shortness of breath, these symptoms can make ...

Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and a ...

What triggers an asthma attack can differ from person to person. For people with allergies, the symptoms can be triggered by breathing in pollen, dust mites, or mould. For some, smoke, fumes ...

Over the past 50 years, treatment options in the event of an asthma or COPD attack—a similar event—have been relatively unchanged. "The only treatment we have for attacks are steroids ...

A first treatment has been found for chronic asthma in 50 years and could be “game changing” in preventing deadly attacks. Scientists have discovered benralizumab could tackle suffocating ...

First new treatment for asthma attacks in 50 years hailed as 'game-changer' Doctors and patients have hailed a new treatment for serious asthma and chronic obstructive pulmonary disease (COPD) attacks ...

During a late night storm, an estimated 10,000 people were rushed to hospitals with severe asthma attacks ... and pollen seasons last much longer. Extreme weather events, including thunderstorms ...

If you experience asthma attacks or more symptoms as a result, you can manage them through different treatments. Consult your healthcare team for the best guidance on managing asthma. Reducing ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients. A clinical trial of the drug benralizumab showed it was far more effective than ...

with more extreme weather, extended pollen seasons and a rise in Australians reporting hay fever. The first time many Australians heard of thunderstorm asthma was in November 2016, when a major event ...

(RTTNews) - Researchers at King's College London have found a new treatment for asthma attacks, which could be a "game-changer" for the patients. Lead investigator Prof Mona Bafadhel, of King's ...